Remote Stemline Therapeutics Jobs
Upgrade to Premium for unlimited access to the largest remote job platform
- 100,000+ Global Remote Companies
- AI Deep Matching: Find jobs where you're a top 5 candidate
- Priority Access to Recruiters as a Certified Premium Talent
0 jobs found
0 jobs found
Sort by:
Relevance
Regulatory Affairs CMC Specialist/Manager, GRAO
Regulatory Affairs CMC Specialist/Manager, GRAO
11 days ago
Stemline Therapeutics
77% flex
Matchscore
- Full time
- Remote: European Union
Medical Science Liaison, Solid Tumor (Northern CA/PNW)Medical Science Liaison, Solid Tumor (Northern CA/PNW)
11 days ago
Stemline Therapeutics
72% flex
Matchscore
- Full time
- Remote: California (USA)
Global Market Access and Reimbursement Product Lead, Solid TumorsGlobal Market Access and Reimbursement Product Lead, Solid Tumors
11 days ago
Stemline Therapeutics
77% flex
Matchscore
- Full time
- Remote: European Union
Medical Science Liaison, Solid Tumor (NYC)Medical Science Liaison, Solid Tumor (NYC)
11 days ago
Stemline Therapeutics
72% flex
Matchscore
- Full time
- Remote: New York (USA)
Medical Science Liaison, Solid Tumor (Southern CA/Hawaii)Medical Science Liaison, Solid Tumor (Southern CA/Hawaii)
11 days ago
Stemline Therapeutics
72% flex
Matchscore
- Full time
- Remote: Hawaii (USA)
Regional Director, Solid Tumor Medical Science Liaisons (MSLs)-Western USRegional Director, Solid Tumor Medical Science Liaisons (MSLs)-Western US
30+ days ago
Stemline Therapeutics
72% flex
Matchscore
- Full time
- Remote: United States
New!
Do you want to see hybrid jobs?
More job openings are available if you are open to hybrid remote job positions.
Include hybrid jobs
Are you looking for a Remote Stemline Therapeutics Jobs?
Discover more about Stemline Therapeutics ?
Stemline is a commercial-stage biopharmaceutical company committed to applying our scientific leadership and commercial expertise to transform the lives of patients with cancer.
ELZONRIS a targeted therapy directed to CD123, is FDA-approved and commercially available in the U.S. for the treatment of adult and pediatric patients, two years and older, with BPDCN. In Europe, a marketing authorization application (MAA) is under review by the European Medicines Agency (EMA).
Inspired by the goal to improve outcomes for patients with unmet medical needs,
Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer. Currently our clinical-stage product candidates in include ELZONRIS, SL-701 and SL801.
